Healthcare ❯Medicine ❯Pharmaceuticals ❯Alzheimer's Disease

Donanemab

FDA Approves Donanemab: A Breakthrough in Early Alzheimer’s Treatment

FDA Panel Recommends Approval of Promising Alzheimer's Drug Donanemab

FDA Reviewers Weigh Safety and Approval Scope for Eli Lilly’s Alzheimer’s Drug